【24h】

Vertebral fracture and cortical bone changes in corticosteroid-induced osteoporosis.

机译:皮质类固醇诱发的骨质疏松症的椎体骨折和皮质骨改变。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Despite an intriguing understanding of trabecular bone dynamics, little is known about corticosteroid-induced cortical bone loss and fractures. Recently, we verified a steroid-induced decrease in cortical bone volume and density using peripheral quantitative computed tomography (pQCT) in adult asthmatic patients given oral corticosteroids. Subsequently, the pQCT parameters and presence of vertebral fractures were investigated to further clarify the role of cortical bone quality in fractures in 86 postmenopausal (>5 years after menopause) asthmatic patients on high-dose oral steroid (>10 g cumulative oral prednisolone) (steroid group) and 194 age-matched controls (control group). Cortical and trabecular bone was subjected to measurement of various parameters using pQCT (Stratec XCT960). Relative Cortical Volume (RCV) was calculated by dividing the cortical area by the total bone area. Strength Strain Index (SSI) was determined in the radius based on the density distribution around the axis. Spinal fracture was assessed on lateral radiographs. Patients treated with high doses of oral steroid (>10 g cumulative oral prednisolone) were found to have an increased risk of fracture compared with control women receiving no steroid medication (odds ratio, 8.85; 95% CI, 4.21-18.60) after adjustment was made for years since menopause, body mass index and RCV. In both groups, the diagnostic and predictive ability of the pQCT parameters for vertebral fracture was assessed by the areas under their receiver operating characteristic (ROC) curves. All parameters were found to be significant predictors ( p<0.0001) in the control group. In the steroid group, however, the cortical bone mineral density (BMD) ( p = 0.001), RCV ( p<0.0001) and SSI ( p = 0.001) were found to be significant predictors, but not trabecular BMD ( p = 0.176). For comparison between the two groups, thresholds of all parameters for vertebral fracture were also calculated by the point of coincidence of sensitivity with specificity in ROC testing and the 90th percentile value. Although a rise in fracture threshold in the steroid group was suggested, considerable difference in the values obtained by the two methods of calculation precluded any conclusion. High-dose oral steroid administration was associated with an increased risk of fracture. Cortical bone parameters obtained by pQCT could play a role as good predictors of future corticosteroid-induced vertebral fractures.
机译:尽管对小梁骨动力学有一个有趣的了解,但对皮质类固醇引起的皮质骨丢失和骨折所知甚少。最近,我们通过外周定量计算机体层摄影术(pQCT)验证了口服皮质类固醇的成年哮喘患者中类固醇诱导的皮质骨体积和密度的降低。随后,研究了pQCT参数和椎骨骨折的存在,以进一步阐明皮质激素在86例高剂量口服类固醇(> 10 g累积口服泼尼松龙)的绝经后(绝经后> 5年)哮喘患者中的作用类固醇组)和194个年龄匹配的对照组(对照组)。使用pQCT(Stratec XCT960)对皮质和小梁骨进行各种参数的测量。通过将皮层面积除以总骨面积来计算相对皮层体积(RCV)。基于围绕轴的密度分布,在半径中确定强度应变指数(SSI)。在侧面X光片上评估脊柱骨折。与调整后未接受类固醇药物治疗的对照组女性相比,接受高剂量口服类固醇激素治疗(> 10 g累积口服泼尼松龙)的骨折风险增加(赔率,8.85; 95%CI,4.21-18.60)。自更年期以来制造的体重指数和RCV。在两组中,pQCT参数对椎骨骨折的诊断和预测能力均通过其受体工作特征(ROC)曲线下的面积进行评估。在对照组中发现所有参数都是重要的预测指标(p <0.0001)。然而,在类固醇组中,发现皮质骨矿物质密度(BMD)(p = 0.001),RCV(p <0.0001)和SSI(p = 0.001)是重要的预测指标,但不是小梁BMD(p = 0.176) 。为了进行两组之间的比较,还通过ROC测试中灵敏度与特异性的符合点以及第90个百分位值来计算椎骨骨折所有参数的阈值。尽管建议类固醇组骨折阈值升高,但是通过两种计算方法获得的值存在较大差异,因此无法得出任何结论。大剂量口服激素治疗与骨折风险增加有关。通过pQCT获得的皮质骨参数可以作为未来皮质类固醇诱发的椎体骨折的良好预测指标。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号